Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
158,835,667
-
Number of holders
-
232
-
Total 13F shares, excl. options
-
96,046,069
-
Shares change
-
-2,875,521
-
Total reported value, excl. options
-
$3,725,506,174
-
Value change
-
-$125,135,262
-
Put/Call ratio
-
92%
-
Number of buys
-
122
-
Number of sells
-
-113
-
Price
-
$38.79
Significant Holders of TG THERAPEUTICS, INC. - COMMON STOCK (TGTX) as of Q2 2021
301 filings reported holding TGTX - TG THERAPEUTICS, INC. - COMMON STOCK as of Q2 2021.
TG THERAPEUTICS, INC. - COMMON STOCK (TGTX) has 232 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 96,046,069 shares
of 158,835,667 outstanding shares and own 60.47% of the company stock.
Largest 10 shareholders include FMR LLC (18,677,515 shares), VANGUARD GROUP INC (11,725,344 shares), BlackRock Inc. (8,352,359 shares), WELLINGTON MANAGEMENT GROUP LLP (4,247,677 shares), Capital World Investors (4,171,302 shares), ALKEON CAPITAL MANAGEMENT LLC (4,082,495 shares), STATE STREET CORP (3,612,147 shares), RA CAPITAL MANAGEMENT, L.P. (3,342,743 shares), LORD, ABBETT & CO. LLC (2,826,762 shares), and MAVERICK CAPITAL LTD (2,821,079 shares).
This table shows the top 232 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.